Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
07115602
ABSTRACT:
The invention relates to 7-(4-tert butyl-cyclohexyl)-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
REFERENCES:
patent: 3840537 (1974-10-01), Garside et al.
patent: 3941785 (1976-03-01), Clarke et al.
patent: 4278673 (1981-07-01), Hartely et al.
patent: 6362178 (2002-03-01), Niewohner et al.
patent: 2255172 (1973-05-01), None
patent: 2364076 (1974-07-01), None
patent: 2811780 (1978-09-01), None
patent: 1092719 (2001-04-01), None
patent: 9924433 (1999-05-01), None
patent: 9967244 (1999-12-01), None
Granata et al,PubMed Abstract 12876405, also cited as Int. Arch. Allergy. Immunol., 131/3,153-63(2003).
Scott et al, Pubmed Abstract 12783578, also cited as Expert Opin. Ther. Targets, 7/3,427-40(2003).
Giembycz MA., PubMed Abstract 11772257, also cited as Expert Opin. Investig. Drugs,10/7,1361-79(2001).
Strurton, et al, PubMed Abstract 12010850, also cited as Chest, 121/5, 192S-196S(2002).
Jacob et al, PubMed Abstract 12185965, also cited as Therapie, 57/2,163-8(2002).
Barnette, M., “PDE 4 Inhibitors in Asthma and Chronic Obstructive Pulmonary Disease (COPD)” Progress in Drug Research, 53: 193-229 (1999).
Dyke, H., Montana, J., “The Therapeutic Potential of PDE4 Inhibitors”, Exp. Opin. Invest. Drugs, 8: 1301-1325 (1999).
Duplantier, A., Biggers, M., Chambers, R., Cheng, J., Cooper, K., Damon, D., Eggler, J., Kraus, K., Marfat, A., Masamune, H. Pillar, J., Shirley, J., Umland, J., Watson, J., “Biarylcarboxylic Acids and —amides: Inhibition of Phosphodiesterase Type IV Versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret”, J. Med. Chem., 39; 120-125 (1996).
Alonso-Alija Cristina
Bischoff Hilmar
Burkhardt Nils
Cuthbert Nigel J.
Fitzgerald Mary F.
Bayer Aktiengesellschaft
Tucker Zachary C.
Wilson James O.
LandOfFree
Heterocycles 3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycles 3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycles 3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620002